Shenzhen New Industries Biomedical (300832) — Tangible Net Worth Ratio
Shenzhen New Industries Biomedical (300832) has a Tangible Net Worth Ratio of 97.2% as of September 2025. This metric is calculated by deducting intangible assets (CN¥240.58 Million) from net assets (CN¥8.74 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Shenzhen New Industries Biomedical (300832) net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Shenzhen New Industries Biomedical Tangible Net Worth Ratio (2012–2024)
This chart shows how Shenzhen New Industries Biomedical's Tangible Net Worth Ratio has changed across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 97.2%, reflecting net assets of CN¥8.74 Billion with intangible assets of CN¥240.58 Million CNY. Also explore Shenzhen New Industries Biomedical (300832) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Shenzhen New Industries Biomedical (2012–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Shenzhen New Industries Biomedical from 2012 to 2024, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Shenzhen New Industries Biomedical (300832) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 97.1% | CN¥8.58 Billion | CN¥245.06 Million | CN¥9.62 Billion | ▼ -0.6 pp |
| 2023 | 97.8% | CN¥7.54 Billion | CN¥169.46 Million | CN¥8.22 Billion | ▲ +0.4 pp |
| 2022 | 97.3% | CN¥6.40 Billion | CN¥172.48 Million | CN¥7.01 Billion | ▼ -1.0 pp |
| 2021 | 98.3% | CN¥5.61 Billion | CN¥94.56 Million | CN¥6.14 Billion | ▲ +0.4 pp |
| 2020 | 97.9% | CN¥4.80 Billion | CN¥98.91 Million | CN¥5.31 Billion | ▲ +1.2 pp |
| 2019 | 96.7% | CN¥3.14 Billion | CN¥102.59 Million | CN¥3.46 Billion | ▼ -0.9 pp |
| 2018 | 97.7% | CN¥2.37 Billion | CN¥55.28 Million | CN¥2.64 Billion | ▲ +0.9 pp |
| 2017 | 96.8% | CN¥1.77 Billion | CN¥57.43 Million | CN¥2.02 Billion | ▲ +0.9 pp |
| 2016 | 95.8% | CN¥1.42 Billion | CN¥59.10 Million | CN¥1.61 Billion | ▲ +1.6 pp |
| 2015 | 94.3% | CN¥1.02 Billion | CN¥58.75 Million | CN¥1.15 Billion | ▼ -4.8 pp |
| 2014 | 99.1% | CN¥610.52 Million | CN¥5.52 Million | CN¥745.44 Million | ▲ +0.6 pp |
| 2013 | 98.5% | CN¥378.84 Million | CN¥5.63 Million | CN¥540.96 Million | ▲ +0.7 pp |
| 2012 | 97.8% | CN¥248.18 Million | CN¥5.53 Million | CN¥313.11 Million | — |